EV/EBITDA - Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) - Alpha Spread

Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705

Watchlist Manager
Hunan Jiudian Pharmaceutical Co Ltd Logo
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
Watchlist
Price: 24.63 CNY 13.45% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Hunan Jiudian Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

23
Current
27.7
Median
13.9
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
23
=
Enterprise Value
11.8B CNY
/
EBITDA
511.1m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
16.9
2-Years Forward
EV/EBITDA
13.4
3-Years Forward
EV/EBITDA
10.5

See Also

Discover More